Technical Analysis for HRTX - Heron Therapeutics, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New 52 Week Closing Low | Bearish | -3.13% | |
| 180 Bearish Setup | Bearish Swing Setup | -3.13% | |
| Wide Bands | Range Expansion | -3.13% | |
| Oversold Stochastic | Weakness | -3.13% | |
| Calm After Storm | Range Contraction | -8.82% | |
| Lower Bollinger Band Walk | Weakness | -8.82% | |
| Wide Bands | Range Expansion | -8.82% | |
| Oversold Stochastic | Weakness | -8.82% | |
| New 52 Week Closing Low | Bearish | -7.26% | |
| Calm After Storm | Range Contraction | -7.26% |
| Alert | Time |
|---|---|
| Possible NR7 | about 1 hour ago |
| Down 5% | about 5 hours ago |
| Down 3% | about 5 hours ago |
| Bearish 180 Entry | about 5 hours ago |
| Fell Below Previous Day's Low | about 5 hours ago |
Get a Trading Assistant
- Earnings date: 11/12/2024
Heron Therapeutics, Inc. Description
Heron Therapeutics, Inc., a specialty pharmaceutical company, develops product candidates using its proprietary Biochronomer polymer-based drug delivery platform. The company's drug delivery platform is designed to improve the therapeutic profile of injectable pharmaceuticals by converting them from products that should be injected once or twice per day to products that need to be injected once every one or two weeks. Its lead product candidate, Sustol, is developed for the prevention of both acute- and delayed-onset chemotherapy-induced nausea and vomiting for patients undergoing emetogenic chemotherapy. The company was formerly known as A.P. Pharma, Inc. and changed its name to Heron Therapeutics, Inc. in January 2014. Heron Therapeutics, Inc. was founded in 1983 and is headquartered in Redwood City, California.
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Medicine Clinical Medicine Pharmaceutical Cancer Treatment Oncology Chemotherapy Occupational Safety And Health Antineoplastic Drugs Drug Delivery Nausea
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 3.93 |
| 52 Week Low | 1.04 |
| Average Volume | 1,908,895 |
| 200-Day Moving Average | 2.54 |
| 50-Day Moving Average | 1.78 |
| 20-Day Moving Average | 1.59 |
| 10-Day Moving Average | 1.38 |
| Average True Range | 0.14 |
| RSI (14) | 24.81 |
| ADX | 32.53 |
| +DI | 11.10 |
| -DI | 37.47 |
| Chandelier Exit (Long, 3 ATRs) | 1.56 |
| Chandelier Exit (Short, 3 ATRs) | 1.47 |
| Upper Bollinger Bands | 2.16 |
| Lower Bollinger Band | 1.01 |
| Percent B (%b) | 0.09 |
| BandWidth | 72.49 |
| MACD Line | -0.19 |
| MACD Signal Line | -0.13 |
| MACD Histogram | -0.0553 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 1.26 | ||||
| Resistance 3 (R3) | 1.27 | 1.23 | 1.24 | ||
| Resistance 2 (R2) | 1.23 | 1.20 | 1.23 | 1.23 | |
| Resistance 1 (R1) | 1.18 | 1.17 | 1.16 | 1.17 | 1.22 |
| Pivot Point | 1.14 | 1.14 | 1.13 | 1.13 | 1.14 |
| Support 1 (S1) | 1.08 | 1.10 | 1.06 | 1.07 | 1.02 |
| Support 2 (S2) | 1.04 | 1.08 | 1.04 | 1.01 | |
| Support 3 (S3) | 0.99 | 1.04 | 1.00 | ||
| Support 4 (S4) | 0.98 |
